Skip to main content

Online First

Online First
Original Research, Adverse Events, Infusion Issues, Chemotherapy
Incidence of Hypersensitivity Reactions With Rapid Rituximab Infusions for Classical Hematology Indications
Paige Robertson, PharmD, BCOP; Amy Dawson, PharmD, BCOP; Megan Burd, PharmD, BCOP; Lindsay Figg, PharmD, BCOP, DPLA; Lesley Volz, PharmD, BCOP, DPLA
Read More
Online First
Original Research, Cost of Care, Monoclonal Antibodies, Practical Issues in Pharmacy Management
Extending the Microbiologic Stability of Single-Dose Vials of High-Cost Medications to 28 Days Using a Closed-System Drug-Transfer Device
Maha Hassan, BCNSP, BCSCP; Amna Khamis Al Hashar, PhD; Abdulaziz Albadi, MSc; Ramesh Borra, MSc; Merlyn Joy, MSc; Dawood Sulaiman Al Salhi, BCSCP
Read More
Online First
Original Research, Chemotherapy, Leukemia
Evaluation of Post-Nadir Granulocyte Colony-Stimulating Factor in Patients With Acute Myeloid Leukemia Receiving Induction Chemotherapy With a Hypomethylating Agent and Venetoclax
Tayler Clark, PharmD, MSPH; Erin Kennedy, PharmD, BCOP; Alexander Reed, MS; Alice Parish, MSPH; Hui-Jie Lee, PhD; Jordan Huckabee, PharmD, BCOP
Read More
Online First
Original Research, Lung Cancer, Infusion Issues, Oncology Pharmacy Programs/Protocols, Supportive Care
Improving Amivantamab Premedication Compliance by Implementing a Provider Notification
Matthew Gerard Roth, PharmD; Kaiwen Wang, PharmD; Melvin Jose Rivera, PharmD; Whitney E. Lewis, PharmD
Read More
Online First
Original Research, Adverse Events
Comparison of Breakthrough Rates of Pneumocystis jirovecii Pneumonia in Adults With Malignancies Receiving Intravenous or Aerosolized Pentamidine for Prophylaxis
Haley L.T. Peterson, PharmD; Sage B. Greenlee, PharmD, BCIDP; Kelley L. Julian, PharmD, BCOP; Emma J. Jones, PharmD, BCOP; Kali Ditolla, PharmD, BCOP; Hannah Imlay, MD, MS
Read More
Online First
Original Research, Transplant, Infusion Issues, Adverse Events
Twice-Daily Bolus Versus Continuous Infusion Intravenous Tacrolimus for Prophylaxis of Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem-Cell Transplant Recipients
Sean Wilson, PharmD, MS, BCOP; Laura Beth Parsons, PharmD, BCOP; Karin Abernathy, PharmD, BCOP; Rachel Matthews, PharmD, BCOP; Darby Siler, PharmD, BCOP; Minoo Battiwalla, MD, MS
Read More
Online First
Original Research, Adverse Events, PARP Inhibitors, Dose Escalation/Reduction
Incidence of PARP Inhibitor Adverse Events Between Germline Versus Somatic Homologous Recombination Mutations
Lauren S. Yeager, PharmD, BCOP; C. Scott Ellis, PharmD, BCOP; Danielle Otto, PharmD, BCOP; Justine Pickarski, MS, LGC; Taylor A. Rives, MD; Aric Schadler, PhD, et al.
Read More
Online First
Original Research, Chronic Myeloid Leukemia, Chemotherapy, Infections, Technology
Remote Outpatient Temperature Monitoring for Early Detection of Febrile Neutropenia After High-Dose Cytarabine Consolidation Chemotherapy: The REMEDY Pilot Study
Amber B. Clemmons, PharmD, BCOP, FHOPA; Emily Behren Ketchum, PharmD, BCOP; Stephanie Daniels, PA-C; Sarah Jimenez, DNP, AGACNP-BC, AOCNP; Mohammad Mian, MD, PhD, MPH; Locke J. Bryan, MD
Read More
Online First
Original Research, Chemotherapy, Oncology Pharmacy Programs/Protocols
Evaluation of Barriers to Initiating Chemotherapy for Pediatric Patients in the Inpatient Setting
Stephen Ensor, PharmD; Joshua Elder, PharmD, BCPS, BCOP; Kyle Harwood, PharmD, BCOP; Page Holsteen, PharmD, BCPPS
Read More
Online First
Original Research, Chemotherapy, Oncology Pharmacy Programs/Protocols, Practical Issues in Pharmacy Management, Technology
Feasibility of Supplemental Materials Alongside Pharmacist-Led Chemotherapy Education: A Prospective Pilot Study
Neha Betrabet, PharmD, BCOP; Sabrina Cannon, PharmD, BCOP; Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA; Vincent Cascone, PharmD, BCO
Read More
Page 2 of 16
Results 11 - 20 of 152